Alfonso Martinez
Research Associate, Formulation Discovery
Meet the rest of our
See All Team Members
Yasser (Yas) El-Gamal, J.D.
Senior Vice President, Legal Affairs and Chief Intellectual Property Counsel
Joan Nickerson
Chief Administrative Officer
Nia Tatsis, Ph.D.
Executive Vice President and Chief Regulatory and Quality Officer, Vertex Pharmaceuticals
Andrew Geall, Ph.D.
Co-Founder and Chief Development Officer, Replicate Bioscience
Burt Adelman, M.D.
Chairman of the Board; former EVP and Chief Medical Officer, Dyax
Anthony Philippakis, M.D., Ph.D.
Chief Data Officer, Broad Institute of MIT and Harvard
Bo Cumbo
President and Chief Executive Officer, Solid Biosciences
Barry Ticho, M.D., Ph.D.
Chief Medical Officer, Stoke Therapeutics
Scott Vafai, M.D.
Senior Vice President, Clinical Development
Andrew Ashe, J.D.
President, Chief Operating Officer and General Counsel
Allison Dorval
Chief Financial Officer
Sekar Kathiresan, M.D.
Co-Founder, Chief Executive Officer and Board Member
Michael MacLean
Chief Financial Officer, Avidity Biosciences
Sheila Mikhail, J.D.
Co-Founder and Chief Executive Officer, Jurata Thin Film
Kiran Musunuru, M.D., Ph.D.
Professor of Cardiovascular Medicine and Genetics, Perelman School of Medicine at the University of Pennsylvania
Troy Lister, Ph.D.
Chief Scientific Officer
Jennifer Robinson
Senior Vice President, Investor Relations and Corporate Communications
Daniel J. Rader, M.D.
Chair, Department of Genetics, University of Pennsylvania
Issi Rozen
Venture Partner, GV
Krishna Yeshwant, M.D.
Managing Partner, GV
J. Keith Joung, M.D., Ph.D.
Robert B. Colvin, M.D. Endowed Chair in Pathology and Pathologist, Massachusetts General Hospital; Professor of Pathology, Harvard Medical School
Leslie Stolz, Ph.D.
Senior Vice President, Regulatory Affairs
Lonnel Coats
Former Chief Executive Officer and Director, Lexicon Pharmaceuticals
Eugene Braunwald, M.D.
Distinguished Hersey Professor of Medicine at Harvard Medical School
Jodie Morrison
Chief Executive Officer and Director, Q32 Bio Inc.
